Cited 9 times in
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.